Target intelligence / Profile preview

Bacterial gene expression

Molecular classification
Enzyme, Ribonucleoprotein, Biological process
01

Overview

Bacterial gene expression is the fundamental biological process by which genetic information in a bacterium's DNA is transcribed into RNA and subsequently translated into functional proteins. This process is essential for bacterial survival, replication, and the expression of virulence factors during infection (Nature Reviews Microbiology, 2017). The primary molecular machinery involved includes DNA-dependent RNA polymerase for transcription and the 70S ribosome (comprising the 30S and 50S subunits) for translation (NCBI Bookshelf, 2002). This pathway is a hallmark of antimicrobial therapy, with numerous antibiotic classes specifically designed to exploit the structural differences between prokaryotic and eukaryotic expression machinery. For example, rifamycins target the bacterial RNA polymerase, while aminoglycosides and macrolides target the ribosomal subunits to inhibit protein synthesis (StatPearls, 2023). However, because 'Bacterial gene expression' encompasses an entire pathway rather than a single molecular entity, it is considered a functional category rather than a specific drug target.

Other names
Prokaryotic gene expressionBacterial transcription and translationBacterial protein synthesis
02

Mechanism of action

Inhibition of bacterial RNA polymerase to prevent mRNA synthesis (transcription) or binding to the 30S or 50S ribosomal subunits to arrest protein assembly (translation), ultimately leading to bacteriostatic or bactericidal effects.

03

Biological functions

TranscriptionTranslationProtein synthesisGene regulation
04

Disease associations

Bacterial infectionAntimicrobial resistance
05

Safety considerations

Disruption of the human commensal microbiomeCross-reactivity with human mitochondrial ribosomes (leading to ototoxicity or nephrotoxicity)Rapid development of antibiotic resistance (e.g., target site mutations or efflux pumps)
06

Interacting drugs

Rifampicin

6 more in the full profile.

07

Biomarkers

Minimal inhibitory concentration (MIC)RNA-seq expression profiling16S rRNA sequencingBacterial growth curves

Beyond the preview

Go deeper on Bacterial gene expression.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial gene expression.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call